Trial periods

T1 Control

T2 100 mg/kg Sangrovit®

T3 500 mg/kg Sangrovit®

T4 1000 mg/kg Sangrovit®

Treatment effect (P=)

F

CM

F

CM

F

CM

F

CM

D0 - D21

1.54 ± 0.50

1.50 ± 0.53

1.54 ± 0.50

1.37 ± 0.49

1.55 ± 0.50

1.43 ± 0.50

1.55 ± 0.52

1.48 ± 0.50

0.9116

D21 - D42

1.48 ± 0.50

1.57 ± 0.52

1.36 ± 0.48

1.51 ± 0.53

1.52 ± 0.50

1.35 ± 0.48

1.36 ± 0.48

1.52 ± 0.50

0.5170

D42 - D90

1.46 ± 0.51

1.52 ± 0.51

1.39 ± 0.49

1.48 ± 0.50

1.38 ± 0.50

1.48 ± 0.50

1.38 ± 0.49

1.48 ± 0.52

0.8502

D0 - D90

1.48 ± 0.51

1.53 ± 0.52

1.42 ± 0.49

1.46 ± 0.50

1.45 ± 0.50

1.44 ± 0.50

1.41 ± 0.50

1.49 ± 0.51

0.6922